Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.94), $0.95 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $2.65 million versus the consensus estimate of $4.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.